Eli Lilly and Co. said that following a pre-planned interim analysis for MONARCH 3, the trial met its primary endpoint of demonstrating statistically significant improvement in progression-free survival. In addition, improvement was shown in a key secondary endpoint of objective response rate.
The Cancer Letter sent the following questions to the University of Utah and a nearly identical list of questions to Soon-Shiong's spokesperson. Julie Kiefer, manager, scientific communications at the University of Utah, provided responses to these questions. No response was received from Soon-Shiong's offices.
Starting in 2008, I worked closely with Peter Phillips to establish the Children's Brain Tumor Tissue Consortium designed to generate a biorepository of rare biospecimens, with associated clinical information and genomic data, that could be shared with the research community.
Under ordinary circumstances, a $12 million gift from a charitable foundation to a university is a cause for celebration.
The text of the petition follows:
Nearly 100 cancer patients and others gather for a march to University of Utah President David Pershing's office on April 24, calling for the reinstatement of Mary Beckerle as director and CEO of the Huntsman Cancer Institute.Cover Photo by Scott G Winterton, Deseret NewsA week after her abrupt firing, Mary Beckerle is back in her job as director and CEO of the Huntsman Cancer Institute.
The American Health Care Act would have a negative impact on affordability and patient access to cancer screening and treatment, according to a survey conducted by the National Comprehensive Cancer Network.
Up to 480 March for Science rallies are scheduled to take place on Earth Day, April 22 in almost 500 cities in at least 37 countries, according to the movement's organizers.
Enrolling less homogeneous patient groups in clinical trials while maintaining safety may lead to a more accurate description of a drug's safety and efficacy, FDA officials wrote in an article published April 20 in the New England Journal of Medicine.
When the University of Utah officials unexpectedly fired Mary Beckerle from her job as CEO and director of the Huntsman Cancer Institute earlier this week, they made an enemy few people in the state would wish for: the powerful Huntsman family.
